Balchem Corporation (BCPC)

30.31 -0.25  -0.82%  May 25, 11:00PM Go Pro
Watch this stock
View Full Chart BCPC Price Chart

Key Stats

Market Cap 885.36M
Revenue Growth 4.38%
Profit Margin 12.16%
Earnings Yield 4.26%
Dividend Yield 0.60%
Earnings Per Share TTM 1.29
PE Ratio 23.50
Price / Sales Ratio 3.001
52 Week High 47.23
52 Week Low 26.56
Beta 0.7129
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 10 BALCHEM CORP Files SEC form 10-Q, Quarterly Report
May 07 Why the Street Should Love Balchem's Earnings Fool
May 03 Balchem Increases Sales but Misses Estimates on Earnings Fool
May 02 Balchem Corporation (BCPC) Misses Q1 EPS by 1c Street Insider
May 02 Basic Materials Sector Wrap Fox Business
May 02 Why Balchem Shares Popped Fool
May 02 Share an idea on $BCPC Nice! by TradeThat
May 02 BALCHEM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Finan...
May 02 Balchem Corporation Announces First Quarter 2012 Results GlobeNewswire
May 02 Q1 2012 Balchem Corp Earnings Release - 09:30 am ET
Mar 20 $BCPC is under the radar play on rebound in $UNG. Earnings were hurt bc 1 division was hurt by drop in nat gas prices. by CompassCapital
Mar 12 Go Pause Go Candidates for tmrw (Inside day after range breakout previous day): $NUS $LII $MNST $WHR $ACXM $BCPC $GTAT $DVR by TheEquitiesRoom
Mar 06 $BCPC New 52 Week Low - Crossed daily lows support. by TradeIdeasQuant
Mar 05 Current Shortlist: $BCPC, $APOL, $NPK, $EDMC, $DGI, $Cel, $NIHD, $KEY.CA, $HPQ, $PMFG and $AMRS (not on my filter bc MC<300M) by techtrading1

Profile

Exchange: NASDAQGS       Sector: Basic Materials       Industry: Chemicals - Major Diversified

Balchem Corporation engages in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally. Its Specialty Products segment offers ethylene oxide, which is used to sterilize medical devices; ethylene oxide blends used in killing bacteria, fungi, and insects in spices and other seasoning materials; and propylene oxide, which controls insects and microbiological spoilage, as well as reduces bacterial and mold contamination in shell and processed food. The company’s Food, Pharma & Nutrition segment provides microencapsulation solutions for various applications in food, pharmaceutical, and nutritional ingredients to improve the performance of nutritional fortification, processing, mixing, and packaging applications and shelf-life; markets human grade choline nutrient products for wellness applications; and offers granulated calcium carbonate products, which are used in or in conjunction with over-the-counter and prescription pharmaceuticals for the treatment of osteoporosis, gastric disorders, and calcium deficiencies. Balchem’s Animal Nutrition & Health segment provides animal nutritional products, including REASHURE Choline, an encapsulated choline product; NITROSHURETM, an encapsulated urea supplement; and NIASHURETM, a microencapsulated niacin product that boosts health and milk production in transition and lactating dairy cows. This segment also markets chelated mineral supplements for use in animal feed; manufactures and supplies basic choline chloride, an essential nutrient primarily for the poultry and swine industries; and manufactures and sells methylamines, which is primarily used in the manufacture of choline products. Balchem sells its products directly, as well as through independent distributors and sales agents. The company was founded in 1967 and is headquartered in New Hampton, New York.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Balchem Corporation is down 27.54% over the last year vs S&P 500 Total Return up 1.62%, Aceto Corporation up 22.50%, and Solazyme down 52.49%.

  • BCPC Total Returns
  • ^SPXTR Total Returns
  • ACET Total Returns
  • SZYM Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Get Quote for

Pro Strategies Featuring BCPC

Did Balchem Corporation make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

BCPC Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
BCPC 30.31 -0.25 -0.82% 885.36M
BCOM 4.20 +0.01 +0.24% 125.54M
BCO 23.23 -0.32 -1.36% 1.089B
BCH 84.05 +0.83 +1.00% 12.18B
ATVI 12.24 +0.14 +1.16% 13.74B
ATV 3.85 +0.05 +1.32% 115.08M
ATSG 5.05 -0.04 -0.79% 323.30M
ATSC 3.21 +0.00 +0.00% 73.73M
ATRO 26.09 -0.54 -2.03% 322.47M
ATRM 0.64 +0.01 +1.59% 6.899M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close